BMC Neurol

1. SONG S, Bai Y, Mu H, Xiao J, et al
   An auxiliary diagnostic strategy for distinguishing Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy: combining platelet-to-lymphocyte ratio and cerebrospinal fluid interleukin-8 levels.
   BMC Neurol. 2025;25:314.
   

   >> Share

   
   
2. KWON S, Seok JM, Lee HL, Chung YH, et al
   Genetic susceptibility of human leukocyte antigen alleles in chronic inflammatory demyelinating polyneuropathy in Korean patients : Short title: HLA alleles and CIDP in Korea.
   BMC Neurol. 2025;25:303.
   

   >> Share

   
   

   
   Brain

3. ABDELHAK A, Cordano C, Duncan GJ, Emberley K, et al
   Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination.
   Brain. 2025;148:3011-3020.
   

   >> Share

   
   
4. NISHIGORI R, Hamatani M, Yoshitomi H, Kimura K, et al
   CD21lo B-cell subsets are recruited to the central nervous system in acute neuromyelitis optica.
   Brain. 2025;148:2995-3010.
   

   >> Share

   
   

   
   J Clin Endocrinol Metab

5. MIYAMURA K, Ito M, Yamaoka H, Hisakado M, et al
   Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease.
   J Clin Endocrinol Metab. 2025 Aug 1:dgaf433. doi: 10.1210.
   

   >> Share

   
   
6. MYERS R, Yildiz M, Nuri Ozbek M, Manzoor J, et al
   Children with diabetes and at least one non-autoimmune feature should be considered for monogenic diabetes testing.
   J Clin Endocrinol Metab. 2025 Aug 1:dgaf430. doi: 10.1210.
   

   >> Share

   
   

   
   J Immunol

7. OO TT, Hariharasubramanian A, Pallikonda Chakravarthy S, Singh N, et al
   Age-related decline in HMGB1-neutralizing IgM autoantibody response impairs resistance to high-fat diet in mice.
   J Immunol. 2025 Jul 29:vkaf172. doi: 10.1093.
   

   >> Share

   
   

   
   J Nephrol

8. PONTICELLI C, Moroni G
   Correction: Targeting autophagy in autoimmune glomerular diseases.
   J Nephrol. 2025 Jul 29. doi: 10.1007/s40620-025-02360.
   

   >> Share

   
   
9. LI J, Tai H, Yang B, Xu J, et al
   Efficacy and safety of TRF-budesonide in IgA nephropathy treatment: a meta-analysis.
   J Nephrol. 2025 Jul 28. doi: 10.1007/s40620-025-02341.
   

   >> Share

   
   

   
   J Neuroimmunol

10. GOMEZ FP, Bake S, Young CR, Sohrabji F, et al
    Therapeutic effects of estrogens on inflammatory demyelination in a mouse model of multiple sclerosis.
    J Neuroimmunol. 2025;407:578698.
    

    >> Share

    
    
11. KAUR G, Kumari P, Devi P, Swaminathan A, et al
    Gut dysbiosis influences the pathophysiology of multiple sclerosis: A case-control study from North India.
    J Neuroimmunol. 2025;407:578696.
    

    >> Share

    
    
12. AKOWUAH PK, Botchway E, Owusu E, Ohene DA, et al
    Are corneal nerve and dendritic cell parameters assessed via corneal confocal microscopy good markers for multiple sclerosis? - A systematic review and meta-analysis.
    J Neuroimmunol. 2025;407:578697.
    

    >> Share

    
    
13. LAUTEN TH, Reed EC, Natour T, Pitts LJ, et al
    Beta adrenergic signaling as a therapeutic target for autoimmunity.
    J Neuroimmunol. 2025;407:578705.
    

    >> Share

    
    

    
    J Neurol

14. DE SOUZA WAGNER PH, de Paiva FA, Mello JS, Silva ALM, et al
    Clinical outcomes after switching from fingolimod to B-cell-depleting therapies in multiple sclerosis: systematic review and meta-analysis.
    J Neurol. 2025;272:546.
    

    >> Share

    
    
15. HOU Y, Zhao B, Zheng J, Dai T, et al
    Clinicopathological profiling and prognosis of idiopathic inflammatory myopathy overlapping with myasthenia gravis: a retrospective cohort study.
    J Neurol. 2025;272:542.
    

    >> Share

    
    

    
    J Rheumatol

16. EL TAL T, Steiman A, Knight A, Hiraki LT, et al
    A Pediatric-Adult Provider Dyad Care Model Improves Transition From Pediatric to Adult Healthcare For Youth with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0046. doi: 10.3899/jrheum.2025-0046.
    

    >> Share

    
    

    
    Mult Scler

17. AXHAUSEN F, Mrochen A, Winter P, Baumgart R, et al
    Disease outcomes following lateral switch among different CD20-antibodies in active multiple sclerosis.
    Mult Scler. 2025 Jul 30:13524585251361330. doi: 10.1177/13524585251361330.
    

    >> Share

    
    
18. CELLERINO M, Massarotti C, Peluffo C, Sirito T, et al
    Relationship between ovarian reserve and disease activity in women with multiple sclerosis.
    Mult Scler. 2025 Jul 28:13524585251356384. doi: 10.1177/13524585251356384.
    

    >> Share

    
    
19. ASP AJ, Jahanian O, Gill ML, Veith DD, et al
    Percutaneous epidural spinal cord stimulation immediately reduces clonus in an individual with multiple sclerosis.
    Mult Scler. 2025 Jul 28:13524585251357143. doi: 10.1177/13524585251357143.
    

    >> Share

    
    

    
    Neurology

20. GAVOILLE A, Leray E, Marignier R, Rollot F, et al
    Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
    Neurology. 2025;105:e213907.
    

    >> Share

    
    
21. BSTEH G, Hegen H
    Bridging the Sex Gap: Confronting Therapeutic Inertia in Women With Multiple Sclerosis.
    Neurology. 2025;105:e214073.
    

    >> Share

    
    

    
    PLoS One

22. HO MKH, Santhireswaran A, Gomes T, Mamdani M, et al
    Comparative effectiveness and safety of insulin reference biologics versus biosimilars for types 1 and 2 diabetes mellitus: Protocol for a systematic review of real-world studies.
    PLoS One. 2025;20:e0329299.
    

    >> Share

    
    
23. CARR ALJ, Shah R, Marfil-Garza BA, Lam A, et al
    Sequential islet transplants for type 1 diabetes are not associated with sustained or cumulative increases in hepatic portal venous pressure.
    PLoS One. 2025;20:e0329074.
    

    >> Share

    
    
24. ATTAR A, Alshaikh H, Alharbi G, Aletani T, et al
    Outcomes of myasthenia gravis patients admitted to the Intensive Care Unit: Experience from a tertiary care center in Saudi Arabia.
    PLoS One. 2025;20:e0328648.
    

    >> Share

    
    

    
    Thyroid

25. CIAMPA DA, Comi S, Cosentino G, Menconi F, et al
    Letter: Prolonged Treatment with Sirolimus (Rapamycin) for Graves' Orbitopathy.
    Thyroid. 2025 Jul 29. doi: 10.1177/10507256251363145.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share